Skip to main content

AstraZeneca will cap inhaler costs at $35 per month

By The Washington Post  
   March 19, 2024

The cost-reduction strategy follows a similar move from Boehringer Ingelheim, a rival in the medical device sector.

Full story


Get the latest on healthcare leadership in your inbox.